Improper prescribing of controlled substances (IPCS) contributes to opioid addictions and deaths by overdose. Studies conducted to date have largely lacked a theoretical framework and ignored the interaction of individual with environmental factors. We conducted a mixed-method analysis of published reports on 100 cases that occurred in the United States. An average of 17 reports (e.g., from medical boards) per case were coded for 38 dichotomous variables describing the physician, setting, patients, and investigation. A theory on how the case occurred was developed for each case. Explanatory typologies were developed and then validated through hierarchical cluster analysis. Most cases involved physicians who were male (88%), >40 years old (90%), non-board certified (63%), and in small private practices (97%); 54% of cases reported facts about the physician indicative of self-centered personality traits. Three explanatory typologies were validated. Increasing oversight provided by peers and trainees may help prevent improper prescribing of controlled substances.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
2.
ArfkenC. L.JohansonC. E.di MenzaS.SchusterC. R. (2010). Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians. Journal of Substance Abuse Treatment, 39, 96-104. doi:10.1016/j.jsat.2010.05.004
3.
AroraK. S.DouglasS.Dorr GooldS. (2014). What brings physicians to disciplinary review? A further subcategorization. AJOB Empirical Bioethics, 5(4), 53-60. doi:10.1080/23294515.2014.920427
4.
DuBoisJ. M.CarrollK.GibbT.KrausE.RubbelkeT.VasherM.AndersonE. E. (2012a). Environmental factors contributing to wrongdoing in medicine: A criterion-based review of studies and cases. Ethics & Behavior, 22, 163-188
5.
DuBoisJ. M.KrausE.VasherM. (2012b). The Development of a Taxonomy of Wrongdoing in Medical Practice and Research. American Journal of Preventive Medicine, 42(1), 89-98. doi:10.1016/j.amepre.2011.08.027
6.
DuBoisJ. M.AndersonE.E.ChibnallJ. (2013a). Understanding the severity of wrondoing in healthcare delivery and research: Lessons learned from a historiometric study of 100 cases. American Journal of Bioethics, Primary Research, 4(3), 39-48.
7.
DuBoisJ. M.AndersonE. E.ChibnallJ.CarrollK.GibbT.OgbukaC.RubbelkeT. (2013b). Understanding research misconduct: a comparative analysis of 120 cases of professional wrongdoing. Accountability in Research-Policies and Quality Assurance, 20(5-6), 320-338. doi:10.1080/08989621.2013.822248.
8.
BanduraA.UnderwoodB.FromsonM. (1975). Disinhibition of aggression through diffusion of responsibility and dehumanization of victims. Journal of Research in Personality, 9, 253-269.
9.
BennettA.ElmanC. (2006). Qualitative research: Recent developments in case study methods. Annual Review of Political Science, 9(1), 455-476. doi:10.1146/annurev.polisci.8.082103.104918
10.
BramstedtK. A.KassimatisK. (2004). A study of warning letters issued to institutional review boards by the United States Food and Drug Administration. Clinical and Investigative Medicine/Medecine Clinique et Experimentale, 27, 316-323. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15675112
Center for Studying Health System Change. (2009). A snapshot of U.S. physicians: Key findings from the 2008 health tracking physician survey. Data Bulletin, 35(September), 1-11. Retrieved from http://www.hschange.com/CONTENT/1078/1078.pdf
13.
CheatleM. D.SavageS. R. (2012). Informed consent in opioid therapy: A potential obligation and opportunity. Journal of Pain and Symptom Management, 44(1), 105-116.
Council on Scientific Affairs. (1982). Drug abuse related to prescribing practice. Journal of the American Medical Association, 247, 864-866.
17.
DartR. C.SurrattH. L.CiceroT. J.ParrinoM. W.SevertsonS. G.Bucher-BartelsonB.GreenJ. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine, 372, 241-248. doi:10.1056/NEJMsa1406143
18.
DavisM. S. (2003). The role of culture in research misconduct. Accountability in Research, 10, 189-201.
19.
DineenK. K.DuBoisJ. M. (2016). Between a rock and a hard place: Can physicians prescribe opioids to treat pain adequately while avoiding legal sanction?American Journal of Law & Medicine, 42, 7-52.
20.
DuBoisJ. M.CarrollK.GibbT.KrausE.RubbelkeT.VasherM.AndersonE. E. (2012). Environmental factors contributing to wrongdoing in medicine: A criterion-based review of studies and cases. Ethics & Behavior, 22, 163-188.
21.
DuBoisJ. M.DuekerJ. M. (2009). Teaching and assessing the responsible conduct of research: A delphi consensus panel report. The Journal of Research Administration, 40(1), 49-70.
22.
ElmanC. (2005). Explanatory typologies in qualitative studies of international politics. International Organization, 59, 293-326. doi:10.1017/s0020818305050101
23.
GeorgeA.BennettA. (2005). Case studies and theory development in the social sciences. Cambridge MA: MIT Press.
GreenbergJ. (1993). Stealing in the name of justice: Informational and interpersonal moderators of theft reactions to underpayment inequity. Organizational Behavior and Human Decision Processes, 54, 81-103. doi:10.1006/obhd.1993.1004
26.
GroverS. L. (1993). Why professionals lie: The impact of professional role conflict on reporting accuracy. Organizational Behavior and Human Decision Processes, 55, 251-272. doi:10.1006/obhd.1993.1033
27.
HegartyW.SimsH. J. (1978). Some determinants of unethical decision behavior: An experiment. Journal of Applied Psychology, 63, 451-457
28.
HellmannD. (2009). Prosecuting doctors for trusting patients. George Mason Law Review, 16, 701-745.
29.
HeumannM.PinaireB.BurgerS. (2009). Bad medicine: On disciplining physician felons. Cardozo Journal of Conflict Resolution, 11, 133-180.
30.
HeumannM.PinaireB.LermanJ. (2007-2008). Prescribing justice: The law and politics of discipline for physician felony offenders. Boston University Public Interest and Law Journal, 17, 1-38.
31.
HoffmannD. E. (2008). Treating pain verses reducing drug diversion and abuse. Saint Louis University Journal of Health Law & Policy, 1, 231-310.
32.
HoffmannD. E. (2008-2009). Physicians who break the law. Saint Louis University Law Journal, 53, 1049-1088.
33.
HoffmannD. E.TarzianA. J. (2003). Achieving the right balance in oversight of physician opioid prescribing for pain: The role of state medical boards. Journal of Law Medicine & Ethics, 31, 21-40.
34.
HoltmanM. C. (2007). Disciplinary careers of drug-impaired physicians. Social Science & Medicine, 64, 543-553. doi:10.1016/j.socscimed.2006.09.016
35.
Institute of Medicine. (2011). Relieving pain in America: A blueprint for transforming prevention, care, education, and research. Washington DC: National Academies Press.
36.
JansenE.Von GlinowM. A. (1985). Ethical ambivalence and organizational reward systems. The Academy of Management Review, 10, 814-822.
37.
JenningsM. (2006). The seven signs of ethical collapse: How to spot moral meltdowns in companies . . . before it’s too late. New York, NY: St. Martins Press.
38.
JonesC. A. (2010). A reason to doubt: The suppression of evidence and the inference of innocence. Journal of Criminal Law & Criminology, 100, 415-474.
39.
JonesC. M.PaulozziL. J.MackK. A. (2014). Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008-2011. JAMA Internal Medicine, 174, 802-803. doi:10.1001/jamainternmed.2013.12809
40.
JungP.LurieP.WolfeS. M. (2006). U.S. physicians disciplined for criminal activity. Health Matrix, 16, 335-350.
41.
Keith-SpiegelP.KoocherG. P. (2005). The IRB paradox: Could the protectors also encourage deceit?Ethics & Behavior, 15, 339-349. doi:10.1207/s15327019eb1504_5
42.
KohatsuN. D.GouldD.RossL. K.FoxP. J. (2004). Characteristics associated with physician discipline: A case-control study. Archives of Internal Medicine, 164, 653-658.
43.
KreekM. J.LevranO.ReedB.SchlussmanS. D.ZhouY.ButelmanE. R. (2012). Opiate addiction and cocaine addiction: Underlying molecular neurobiology and genetics. Journal of Clinical Investigation, 122, 3387-3393. doi:10.1172/JCI60390
44.
LevineR. J. (1992). Clinical trials and physicians as double agents. Yale Journal of Biology and Medicine, 65(2), 65-74. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1519378
45.
MaguireM.ReinerR.MorganR. (2007). The Oxford handbook of criminology. New York, NY: Oxford University Press.
46.
MarshallE. (1999). Clinical research: Shutdown of research at Duke sends a message. Science, 284(5418), 1246.
47.
MartinsonB. C.AndersonM. S.CrainA. L.De VriesR. (2006). Scientists’ perceptions of organizational justice and self-reported misbehaviors. Journal of Empirical Research on Human Research Ethics, 1(1), 51-66.
48.
MeyerW.BernierG. M.Jr. (2002). Potential cultural factors in scientific misconduct allegations. In SteneckN.ScheetzM. (Eds.), Investigating Research Integrity: Proceedings of the First ORI Research Conference on Research Integrity (pp. 163-166). Washington, DC: Department of Health and Human Services.
49.
MilgramS. (1965). Some conditions of obedience and disobedience to authority. Human Relations, 18, 57-76.
50.
NameyE.GuestG.ThairuL.JohnsonL. (2008). Data reduction techniques for large qualitative data sets. In GuestG.MacqueenK. A. (Eds.), Handbook for team-based qualitative research (pp. 137-161). New York, NY: Altamira.
51.
PapadakisM. A.ArnoldG. K.BlankL. L.HolmboeE. S.LipnerR. S. (2008). Performance during internal medicine residency training and subsequent disciplinary action by state licensing boards. Annals of Internal Medicine, 148, 869-876. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18519932
52.
PapadakisM. A.TeheraniA.BanachM. A.KnettlerT. R.RattnerS. L.SternD. T.. . . HodgsonC. S. (2005). Disciplinary action by medical boards and prior behavior in medical school. New England Journal of Medicine, 353, 2673-2682. doi:10.1056/NEJMsa052596
53.
RodwinM. A. (1993). Medicine, money, & morals: Physicians’ conflicts of interest. New York, NY: Oxford University Press.
54.
RollerM. R.LavrakasP. J. (2015). Applied qualitative research design: A total quality framework approach. New York, NY: Guilford Press.
55.
SamenowS. E. (2001). Understanding the criminal mind: A phenomenological approach. Journal of Psychiatry & Law, 29, 275-293.
56.
ShahS.WhittleA.WilfondB.GenslerG.WendlerD. (2004). How do institutional review boards apply the federal risk and benefit standards for pediatric research?Journal of the American Medical Association, 291, 476-482. doi:10.1001/jama.291.4.476
57.
SimontonD. K. (2003). Qualitative and quantitative analyses of historical data. Annual Review of Psychology, 54, 617-640. doi:10.1146/annurev.psych.54.101601.145034
58.
SpickardA.SwiggartW.PichertJ. W.DoddD.ElasyT. A.DixonG. L.ButtsN. L. (2002). Changes made by physicians who misprescribed controlled substances. Journal of Medical Licensure and Discipline, 88, 110-115.
59.
Substance Abuse and Mental Health Services Administration. (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of national findings. Washington DC: U.S. Department of Health and Human Services.
60.
TrevinoL. K.ButterfieldK.McCabeD. (1998). The ethical context in organizations: Influences on employee attitudes and behaviors. Business Ethics Quarterly, 8, 447-476.
61.
VictorB.TrevinoL. K.ShapiroD. L. (1993). Peer reporting of unethical behavior: The influence of justice evaluations and social context factors. Journal of Business Ethics, 12, 253-263.
62.
VogtP. W.VogtE. R.GardnerD. C.HaeffeleL. M. (2014). Selecting the right analyses for your data: Quantitative, qualitative, and mixed methods. New York, NY: Guilford Press.
63.
WalliniusM.JohanssonP.LardenM.DernevikM. (2011). Self-serving cognitive distortions and antisocial behavior among adults and adolescents. Criminal Justice and Behavior, 38, 286-301. doi:10.1177/0093854810396139
64.
WeissR. D.PotterJ. S.FiellinD. A.ByrneM.ConneryH. S.DickinsonW.. . . LingW. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry, 68, 1238-1246. doi:10.1001/archgenpsychiatry.2011.121
65.
WessonD. R.SmithD. E. (1990). Prescription drug abuse: Patient, physician, and cultural responsibilities. Western Journal of Medicine, 152, 613-616.
66.
ZimbardoP. G. (2007). The Lucifer Effect. New York, NY: Random House.
